Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1030

1.

Successful removal of an encrusted metallic ureteral stent using a disposable ureteroscope and Ho:YAG laser lithotripsy.

Kawahara T, Kobayashi K, Kurora S, Yao M, Uemura H.

Urolithiasis. 2019 Nov 7. doi: 10.1007/s00240-019-01171-9. [Epub ahead of print] No abstract available.

PMID:
31701177
2.

[A Case of Polyorchidism Associated with Infertility].

Iwamoto G, Takeshima T, Kuroda S, Yumura Y, Uemura H.

Hinyokika Kiyo. 2019 Oct;65(10):425-427. doi: 10.14989/ActaUrolJap_65_10_425. Japanese.

PMID:
31697889
3.

The interaction between ABCA1 polymorphism and physical activity on the HDL-cholesterol levels in a Japanese population.

Nishida Y, Hachiya T, Hara M, Shimanoe C, Tanaka K, Sutoh Y, Shimizu A, Hishida A, Tsukamoto M, Kadomatsu Y, Oze I, Koyanagi YN, Kuriyama N, Koyama T, Ibusuki R, Takezaki T, Ikezaki H, Furusyo N, Takashima N, Kadota A, Uemura H, Katsuura-Kamano S, Suzuki S, Nakagawa-Senda H, Kuriki K, Mikami H, Nakamura Y, Momozawa Y, Kubo M, Nakatochi M, Naito M, Wakai K.

J Lipid Res. 2019 Nov 6. pii: jlr.P091546. doi: 10.1194/jlr.P091546. [Epub ahead of print]

4.

Assessing the oral health of in-patients with diabetes using a clinical version of the Diabetes Oral Health Assessment Tool© and its association with dental examinations.

Kuwamura Y, Sakamoto E, Sumikawa M, Matsuhisa M, Hinode D, Uemura H, Kishida S.

J Med Invest. 2019;66(3.4):328-336. doi: 10.2152/jmi.66.328.

5.

Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up.

Tomita Y, Kondo T, Kimura G, Inoue T, Wakumoto Y, Yao M, Sugiyama T, Oya M, Fujii Y, Obara W, Motzer RJ, Uemura H.

Jpn J Clin Oncol. 2019 Oct 21. pii: hyz132. doi: 10.1093/jjco/hyz132. [Epub ahead of print]

PMID:
31633185
6.

Factors correlating with recovery of quadriceps strength after double-bundle anterior cruciate ligament reconstruction with hamstring tendon autografts.

Iwame T, Matsuura T, Okahisa T, Iwase J, Uemura H, Sairyo K.

Eur J Orthop Surg Traumatol. 2019 Oct 14. doi: 10.1007/s00590-019-02580-7. [Epub ahead of print]

PMID:
31612316
7.

A Case of Switching from GnRH Agonist to Antagonist for Castration Resistant Prostate Cancer Control.

Sugimura R, Kawahara T, Miyoshi Y, Yao M, Chiba S, Uemura H.

Case Rep Oncol. 2019 Sep 17;12(3):688-692. doi: 10.1159/000502859. eCollection 2019 Sep-Dec.

8.

Role of p38 MAP kinase signaling pathways in storage and voiding dysfunction in mice with spinal cord injury.

Shimizu N, Wada N, Shimizu T, Suzuki T, Kurobe M, Kanai AJ, de Groat WC, Hashimoto M, Hirayama A, Uemura H, Yoshimura N.

Neurourol Urodyn. 2019 Oct 3. doi: 10.1002/nau.24170. [Epub ahead of print]

PMID:
31579964
9.

Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study.

Agarwal N, McQuarrie K, Bjartell A, Chowdhury S, Pereira de Santana Gomes AJ, Chung BH, Özgüroğlu M, Juárez Soto Á, Merseburger AS, Uemura H, Ye D, Given R, Cella D, Basch E, Miladinovic B, Dearden L, Deprince K, Naini V, Lopez-Gitlitz A, Chi KN; TITAN investigators.

Lancet Oncol. 2019 Nov;20(11):1518-1530. doi: 10.1016/S1470-2045(19)30620-5. Epub 2019 Sep 29.

PMID:
31578173
10.

Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer.

Small EJ, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, De Porre P, Smith AA, Zhang K, Lopez-Gitlitz A, Smith MR.

Ann Oncol. 2019 Sep 27. pii: mdz397. doi: 10.1093/annonc/mdz397. [Epub ahead of print]

PMID:
31560066
11.

Longer Control of Nivolumab in Metastatic Renal Cell Carcinoma Patients with End-Stage Kidney Disease on Dialysis.

Morinaga R, Kawahara T, Miyoshi Y, Yao M, Uemura H.

Case Rep Oncol. 2019 Aug 6;12(2):608-612. doi: 10.1159/000501768. eCollection 2019 May-Aug.

12.

Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer.

Morinaga R, Kawahara T, Kuroda S, Inayama Y, Uemura H.

Case Rep Oncol. 2019 Aug 6;12(2):603-607. doi: 10.1159/000502174. eCollection 2019 May-Aug.

13.

Changing the Timing of Enzalutamide Intake from Morning to before Sleep at Night Overcame Enzalutamide-Induced Dysgeusia.

Kawahara T, Miyoshi Y, Yao M, Uemura H.

Case Rep Oncol. 2019 Aug 6;12(2):589-594. doi: 10.1159/000502054. eCollection 2019 May-Aug.

14.

Oral administration of whole dihomo-γ-linolenic acid-producing yeast suppresses allergic contact dermatitis in mice.

Watanabe N, Teradu S, Ohtani M, Uemura H.

Biosci Biotechnol Biochem. 2019 Sep 18:1-8. doi: 10.1080/09168451.2019.1667220. [Epub ahead of print]

PMID:
31532348
15.

Preference for enzalutamide capsules versus tablet pills in patients with prostate cancer.

Ninomiya S, Kawahara T, Tatenuma T, Miyoshi Y, Miyamoto H, Yao M, Uemura H.

Int J Urol. 2019 Sep 18. doi: 10.1111/iju.14101. [Epub ahead of print] No abstract available.

PMID:
31532007
16.

Prostate cancer in Asia: design of a patient registry to inform real-world treatments, outcomes, and quality of life.

Liu Y, Uemura H, Ye D, Lee JY, Chiong E, Pu YS, Razack AHA, Pripatnanont C, Rawal S, Low GKM, Qiu H, Chow WH, Van Kooten Losio M.

Prostate Int. 2019 Sep;7(3):108-113. doi: 10.1016/j.prnil.2018.12.001. Epub 2018 Dec 24.

17.

Targeting castration-resistant prostate cancer with androgen receptor antisense oligonucleotide therapy.

De Velasco MA, Kura Y, Sakai K, Hatanaka Y, Davies BR, Campbell H, Klein S, Kim Y, MacLeod AR, Sugimoto K, Yoshikawa K, Nishio K, Uemura H.

JCI Insight. 2019 Sep 5;4(17). pii: 122688. doi: 10.1172/jci.insight.122688.

18.

Correlation between Automated Bone Scan Index Change after Cabazitaxel and Survival among Men with Castration-Resistant Prostate Cancer.

Miyoshi Y, Sakamoto S, Kawahara T, Uemura K, Yokomizo Y, Uemura H.

Urol Int. 2019;103(3):279-284. doi: 10.1159/000502655. Epub 2019 Aug 28.

PMID:
31461725
19.

An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer.

Tsuchiya T, Imanaka K, Iwaki Y, Oyama R, Hashine K, Yamaguchi A, Uemura H.

Int J Clin Oncol. 2019 Aug 24. doi: 10.1007/s10147-019-01526-7. [Epub ahead of print]

PMID:
31446511
20.

Diagnostic Impacts of Clinical Laboratory Based P2PSA Indexes on Any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml.

Ito K, Yokomizo A, Tokunaga S, Arai G, Sugimoto M, Akakura K, Hasumi H, Sakai H, Ouraji A, Oki R, Kashiwagi E, Kobori Y, Hirama H, Kitoh H, Uemura H, Hakariya T, Suzuki K; and Members of PROPHET.

J Urol. 2019 Aug 20:101097JU0000000000000495. doi: 10.1097/JU.0000000000000495. [Epub ahead of print]

PMID:
31430244
21.

Phase I trial of TAK-385 in hormone treatment-naïve Japanese patients with nonmetastatic prostate cancer.

Suzuki H, Uemura H, Mizokami A, Hayashi N, Miyoshi Y, Nagamori S, Enomoto Y, Akaza H, Asato T, Kitagawa T, Suzuki K.

Cancer Med. 2019 Oct;8(13):5891-5902. doi: 10.1002/cam4.2442. Epub 2019 Aug 19.

22.

The Achievement of Long-Term CRPC Control in a Patient with Enzalutamide-Induced Nausea and Fatigue after Overcoming the Adverse Events with a Temporary Drug Holiday.

Kawahara T, Miyoshi Y, Yao M, Uemura H.

Case Rep Oncol. 2019 Jul 16;12(2):568-572. doi: 10.1159/000501849. eCollection 2019 May-Aug.

23.

Inserting a Metallic Ureteral Stent Using an Antegrade Approach Freed a Patient from Nephrostomy Created due to Hydronephrosis Caused by Bladder Cancer.

Kawahara T, Takamoto D, Miyoshi Y, Yao M, Uemura H.

Case Rep Oncol. 2019 Jul 16;12(2):560-563. doi: 10.1159/000501767. eCollection 2019 May-Aug.

24.

Successful Resection of Cisplatin-Resistant Renal Pelvic Cancer after the Administration of Pembrolizumab as Second-Line Therapy.

Kawahara T, Mochizuki T, Sugimura R, Izumi K, Kuroda S, Miyoshi Y, Nakaigawa N, Yao M, Tanabe M, Uemura H.

Case Rep Oncol. 2019 Jul 16;12(2):548-553. doi: 10.1159/000501715. eCollection 2019 May-Aug.

25.

Long-Term Control of Metastatic Renal Cell Carcinoma Using Pazopanib.

Kawahara T, Takeshima T, Miyoshi Y, Nakaigawa N, Yao M, Tanabe M, Uemura H.

Case Rep Oncol. 2019 Jul 16;12(2):543-547. doi: 10.1159/000501716. eCollection 2019 May-Aug.

26.

A case of allograft ureteral stone successfully treated with antegrade ureteroscopic lithotripsy: use of a 3D-printed model to determine the ideal approach.

Kuroda S, Kawahara T, Teranishi J, Mochizuki T, Ito H, Uemura H.

Urolithiasis. 2019 Oct;47(5):467-471. doi: 10.1007/s00240-019-01153-x. Epub 2019 Aug 9.

PMID:
31399789
27.

Successful treatment for Kaposi sarcoma inflammatory cytokine syndrome in a severe CD4+ lymphocytopenic HIV patient.

Suzuki T, Uemura H, Yanagawa Y, Mizushima D, Aoki T, Watanabe K, Tanuma J, Tsukada K, Teruya K, Gatanaga H, Kikuchi Y, Oka S.

AIDS. 2019 Sep 1;33(11):1801-1802. doi: 10.1097/QAD.0000000000002201. No abstract available.

PMID:
31356257
28.

Impact of pegfilgrastim as primary prophylaxis for metastatic castration-resistant prostate cancer patients undergoing cabazitaxel treatment: an open-label study in Japan.

Kosaka T, Uemura H, Sumitomo M, Harada K, Sugimoto M, Hayashi N, Yoshimura K, Fukasawa S, Ecstein-Fraisse E, Sunaga Y, Oya M.

Jpn J Clin Oncol. 2019 Aug 1;49(8):766-771. doi: 10.1093/jjco/hyz051.

PMID:
31329922
29.

Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout.

Kawamura Y, Nakaoka H, Nakayama A, Okada Y, Yamamoto K, Higashino T, Sakiyama M, Shimizu T, Ooyama H, Ooyama K, Nagase M, Hidaka Y, Shirahama Y, Hosomichi K, Nishida Y, Shimoshikiryo I, Hishida A, Katsuura-Kamano S, Shimizu S, Kawaguchi M, Uemura H, Ibusuki R, Hara M, Naito M, Takao M, Nakajima M, Iwasawa S, Nakashima H, Ohnaka K, Nakamura T, Stiburkova B, Merriman TR, Nakatochi M, Ichihara S, Yokota M, Takada T, Saitoh T, Kamatani Y, Takahashi A, Arisawa K, Takezaki T, Tanaka K, Wakai K, Kubo M, Hosoya T, Ichida K, Inoue I, Shinomiya N, Matsuo H.

Ann Rheum Dis. 2019 Oct;78(10):1430-1437. doi: 10.1136/annrheumdis-2019-215521. Epub 2019 Jul 8.

30.

Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses.

Ohyama C, Kojima T, Kondo T, Naya Y, Inoue T, Tomita Y, Eto M, Hisasue S, Uemura H, Obara W, Kikuchi E, Sharma P, Galsky MD, Siefker-Radtke A, Grossfeld G, Collette S, Gooden K, Kimura G.

Int J Clin Oncol. 2019 Sep;24(9):1089-1098. doi: 10.1007/s10147-019-01450-w. Epub 2019 Jun 19.

PMID:
31218529
31.

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.

Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R, Juárez Soto Á, Merseburger AS, Özgüroğlu M, Uemura H, Ye D, Deprince K, Naini V, Li J, Cheng S, Yu MK, Zhang K, Larsen JS, McCarthy S, Chowdhury S; TITAN Investigators.

N Engl J Med. 2019 Jul 4;381(1):13-24. doi: 10.1056/NEJMoa1903307. Epub 2019 May 31.

PMID:
31150574
32.

Efficacy of acotiamide hydrochloride hydrate added to α-blocker plus cholinergic drug combination therapy.

Sugimoto K, Akiyama T, Matsumura N, Minami T, Uejima S, Uemura H.

Int J Urol. 2019 Aug;26(8):848-849. doi: 10.1111/iju.14019. Epub 2019 May 15. No abstract available.

PMID:
31094024
33.

Associations of Nutrient Patterns with the Prevalence of Metabolic Syndrome: Results from the Baseline Data of the Japan Multi-Institutional Collaborative Cohort Study.

Iwasaki Y, Arisawa K, Katsuura-Kamano S, Uemura H, Tsukamoto M, Kadomatsu Y, Okada R, Hishida A, Tanaka K, Hara M, Takezaki T, Shimatani K, Ozaki E, Koyama T, Suzuki S, Nakagawa-Senda H, Kuriki K, Miyagawa N, Kadota A, Ikezaki H, Furusyo N, Oze I, Ito H, Mikami H, Nakamura Y, Wakai K.

Nutrients. 2019 Apr 30;11(5). pii: E990. doi: 10.3390/nu11050990.

34.

Male CDPX2 patient with EBP mosaicism and asymmetrically lateralized skin lesions with strict midline demarcation.

Horinouchi T, Morisada N, Uemura H, Kobayashi D, Nozu K, Okamoto N, Iijima K.

Am J Med Genet A. 2019 Jul;179(7):1315-1318. doi: 10.1002/ajmg.a.61159. Epub 2019 Apr 29.

PMID:
31034146
35.

Independent relationships of daily life activity and leisure-time exercise with metabolic syndrome and its traits in the general Japanese population.

Uemura H, Katsuura-Kamano S, Iwasaki Y, Arisawa K, Hishida A, Okada R, Tamura T, Kubo Y, Ito H, Oze I, Shimanoe C, Nishida Y, Nakamura Y, Takashima N, Suzuki S, Nakagawa-Senda H, Nishimoto D, Takezaki T, Mikami H, Nakamura Y, Furusyo N, Ikezaki H, Ozaki E, Koyama T, Kuriki K, Endoh K, Naito M, Wakai K; Japan Multi-institutional Collaborative Cohort (J-MICC) Study Group.

Endocrine. 2019 Jun;64(3):552-563. doi: 10.1007/s12020-019-01926-9. Epub 2019 Apr 22.

PMID:
31011988
36.

Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals.

Nakatochi M, Kanai M, Nakayama A, Hishida A, Kawamura Y, Ichihara S, Akiyama M, Ikezaki H, Furusyo N, Shimizu S, Yamamoto K, Hirata M, Okada R, Kawai S, Kawaguchi M, Nishida Y, Shimanoe C, Ibusuki R, Takezaki T, Nakajima M, Takao M, Ozaki E, Matsui D, Nishiyama T, Suzuki S, Takashima N, Kita Y, Endoh K, Kuriki K, Uemura H, Arisawa K, Oze I, Matsuo K, Nakamura Y, Mikami H, Tamura T, Nakashima H, Nakamura T, Kato N, Matsuda K, Murakami Y, Matsubara T, Naito M, Kubo M, Kamatani Y, Shinomiya N, Yokota M, Wakai K, Okada Y, Matsuo H.

Commun Biol. 2019 Apr 8;2:115. doi: 10.1038/s42003-019-0339-0. eCollection 2019.

37.

Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer.

Yasui M, Kawahara T, Izumi K, Yao M, Ishiguro Y, Ishiguro H, Uemura H, Miyoshi Y.

BMC Cancer. 2019 Apr 8;19(1):331. doi: 10.1186/s12885-019-5512-9.

38.

A Novel Approach to Prevent Perioperative Stroke in Patients Undergoing Debranching Thoracic Endovascular Aortic Repair with a Mini-Cardiopulmonary Bypass Support.

Ryomoto M, Tanaka H, Mitsuno M, Yamamura M, Sekiya N, Uemura H, Sato A, Ueda D.

Ann Vasc Surg. 2019 Aug;59:143-149. doi: 10.1016/j.avsg.2018.09.036. Epub 2019 Apr 5.

PMID:
30954589
39.

Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study.

Tomita Y, Fukasawa S, Shinohara N, Kitamura H, Oya M, Eto M, Tanabe K, Saito M, Kimura G, Yonese J, Yao M, Uemura H.

Jpn J Clin Oncol. 2019 Jun 1;49(6):506-514. doi: 10.1093/jjco/hyz026.

PMID:
30941424
40.

Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab.

Tabei T, Nakaigawa N, Kaneta T, Ikeda I, Kondo K, Makiyama K, Hasumi H, Hayashi N, Kawahara T, Izumi K, Osaka K, Muraoka K, Teranishi JI, Miyoshi Y, Yumura Y, Uemura H, Kobayashi K, Inoue T, Yao M.

BMC Cancer. 2019 Apr 2;19(1):298. doi: 10.1186/s12885-019-5510-y.

41.

Usefulness of Abdominal Duplex Ultrasound for Detecting Endoleaks after Endovascular Aneurysm Repair.

Uemura H, Tanaka H, Mitsuno M, Yamamura M, Ryomoto M, Sekiya N, Sato A, Ueda D, Miyamoto Y.

Ann Vasc Dis. 2019 Mar 25;12(1):30-35. doi: 10.3400/avd.oa.18-00108.

42.

A case of genotype-3b hepatitis C virus in which the whole genome was successfully analyzed using third-generation nanopore sequencing.

Uchida Y, Kouyama JI, Naiki K, Uemura H, Tsuji S, Sugawara K, Nakao M, Motoya D, Nakayama N, Imai Y, Tomiya T, Mochida S.

Hepatol Res. 2019 Sep;49(9):1083-1087. doi: 10.1111/hepr.13339. Epub 2019 Jun 13.

PMID:
30924272
43.

Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases.

Uemura H, Uemura H, Nagamori S, Wakumoto Y, Kimura G, Kikukawa H, Yokomizo A, Mizokami A, Kosaka T, Masumori N, Kawasaki Y, Yonese J, Nasu Y, Fukasawa S, Sugiyama T, Kinuya S, Hosono M, Yamaguchi I, Akagawa T, Matsubara N.

Int J Clin Oncol. 2019 May;24(5):557-566. doi: 10.1007/s10147-018-01389-4. Epub 2019 Mar 14.

44.

Genome-wide association meta-analysis and Mendelian randomization analysis confirm the influence of ALDH2 on sleep durationin the Japanese population.

Nishiyama T, Nakatochi M, Goto A, Iwasaki M, Hachiya T, Sutoh Y, Shimizu A, Wang C, Tanaka H, Watanabe M, Hosono A, Tamai Y, Yamada T, Yamaji T, Sawada N, Fukumoto K, Otsuka K, Tanno K, Tomita H, Kojima K, Nagasaki M, Hozawa A, Hishida A, Sasakabe T, Nishida Y, Hara M, Ito H, Oze I, Nakamura Y, Mikami H, Ibusuki R, Takezaki T, Koyama T, Kuriyama N, Endoh K, Kuriki K, Turin TC, Naoyuki T, Katsuura-Kamano S, Uemura H, Okada R, Kawai S, Naito M, Momozawa Y, Kubo M, Sasaki M, Yamamoto M, Tsugane S, Wakai K, Suzuki S.

Sleep. 2019 Jun 11;42(6). pii: zsz046. doi: 10.1093/sleep/zsz046.

PMID:
30810208
45.

Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide.

Kumano Y, Hasegawa Y, Kawahara T, Yasui M, Miyoshi Y, Matsubara N, Uemura H.

Biomed Res Int. 2019 Jan 20;2019:9450838. doi: 10.1155/2019/9450838. eCollection 2019.

46.

Intramucosal gastric cancer on the prepylorus completely resected by underwater endoscopic mucosal resection.

Uemura H, Kono Y, Nakagawa M.

Dig Endosc. 2019 May;31(3):332. doi: 10.1111/den.13375. Epub 2019 Mar 22. No abstract available.

PMID:
30793381
47.

Molecular epidemiology of acute HCV infection in HIV-positive patients from Hong Kong, Taipei, Tokyo.

Sun HY, Uemura H, Wong NS, Chan DP, Wong BC, Lin PH, Su LH, Hung CC, Oka S, Chang SY, Lee SS.

Liver Int. 2019 Jun;39(6):1044-1051. doi: 10.1111/liv.14073. Epub 2019 Mar 13.

PMID:
30770636
48.

Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study.

Tomita Y, Uemura H, Oya M, Shinohara N, Habuchi T, Fujii Y, Kamei Y, Umeyama Y, Bair AH, Rini BI.

BMC Cancer. 2019 Jan 7;19(1):17. doi: 10.1186/s12885-018-5224-6.

49.

HOXA10 expression profiling in prostate cancer.

Hatanaka Y, de Velasco MA, Oki T, Shimizu N, Nozawa M, Yoshimura K, Yoshikawa K, Nishio K, Uemura H.

Prostate. 2019 Apr;79(5):554-563. doi: 10.1002/pros.23761. Epub 2019 Jan 6.

PMID:
30614022
50.

NS5A-P32 deletion as a factor involved in virologic failure in patients receiving glecaprevir and pibrentasvir.

Uemura H, Uchida Y, Kouyama JI, Naiki K, Tsuji S, Sugawara K, Nakao M, Motoya D, Nakayama N, Imai Y, Tomiya T, Mochida S.

J Gastroenterol. 2019 May;54(5):459-470. doi: 10.1007/s00535-018-01543-9. Epub 2019 Jan 5.

PMID:
30612205

Supplemental Content

Loading ...
Support Center